Paolo Castelnuovo Selected Research

Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)

6/2022	Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
1/2022	Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
1/2019	Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas.
1/2018	Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
11/2017	The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
9/2007	Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Castelnuovo Research Topics

Disease

28	Neoplasms (Cancer) 06/2022 - 01/2010
9	Hemorrhage 01/2021 - 03/2009
6	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 06/2022 - 09/2007
5	Adenocarcinoma 01/2019 - 05/2015
4	Cerebrospinal Fluid Leak 01/2021 - 04/2006
3	Asthma (Bronchial Asthma) 05/2022 - 03/2012
3	COVID-19 11/2020 - 01/2020
2	Nasal Polyps (Nasal Polyp) 07/2022 - 11/2016
2	Rhinosinusitis 07/2022 - 12/2020
2	Margins of Excision 01/2022 - 06/2016
2	Carcinoma (Carcinomatosis) 10/2021 - 01/2018
2	Pathologic Constriction (Stenosis) 05/2021 - 02/2004
2	Headache (Headaches) 02/2021 - 01/2021
2	Adenoid Cystic Carcinoma (Cylindroma) 01/2021 - 01/2020
2	Pituitary Neoplasms (Pituitary Adenoma) 11/2019 - 02/2014
2	Adenoma (Adenomas) 11/2019 - 02/2014
2	Epistaxis (Nosebleed) 06/2018 - 03/2009
2	Diplopia (Double Vision) 02/2016 - 02/2014
2	Granuloma 08/2015 - 11/2013
2	Cicatrix (Scar) 08/2012 - 02/2004
1	Hypersensitivity (Allergy) 05/2022
1	Obstructive Sleep Apnea 11/2021
1	Allergic Rhinitis 10/2021
1	Hiccup (Hiccups) 02/2021
1	Paresthesia (Dysesthesia) 02/2021
1	Thinness 01/2021
1	Alopecia (Baldness) 01/2021
1	Osteoradionecrosis 01/2021
1	Infections 01/2021
1	Necrosis 01/2021
1	Mucocele 01/2021
1	Disease Progression 01/2020
1	Prolactinoma (Prolactinomas) 11/2019
1	Pituitary ACTH Hypersecretion 11/2019
1	Wounds and Injuries (Trauma) 02/2019
1	Lymphoma (Lymphomas) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Rhabdomyosarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Meningioma (Meningiomas) 01/2017
1	Inflammation (Inflammations) 01/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016
1	Bronchial Hyperreactivity 01/2016
1	Persistent Infection 01/2016
1	Graves Ophthalmopathy 07/2015

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2022
2	somatostatin receptor 2IBA 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 10/2021 - 12/2020
2	Hormones (Hormone)IBA 11/2019 - 11/2010
2	CholesterolIBA 08/2015 - 11/2013
1	Transcription Factors (Transcription Factor)IBA 06/2022
1	Pharmaceutical PreparationsIBA 05/2022
1	TESIBA 01/2022
1	CatecholaminesIBA 11/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2021
1	Biological ProductsIBA 10/2021
1	PlatinumIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Growth Hormone (Somatotropin)IBA 11/2019
1	A 17 (A-17)IBA 01/2019
1	ethyl 1- ribofuranosyl- 1,2,4- triazole- 3- carboximidateIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Temazepam (Nocturne)FDA LinkGeneric 08/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	4-O-carboxymethylascochlorinIBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	Etoposide (VP 16)FDA LinkGeneric 11/2017
1	GlycosaminoglycansIBA 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	CarcinogensIBA 01/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 09/2013
7	Craniotomy 01/2019 - 04/2006
5	Radiotherapy 01/2021 - 09/2007
4	Drug Therapy (Chemotherapy) 02/2020 - 06/2016
3	Adjuvant Radiotherapy 01/2022 - 05/2015
3	Stents 01/2021 - 06/2009
3	Surgical Flaps 01/2021 - 01/2018
3	Emergency Treatment 02/2019 - 03/2009
2	Endoscopes 01/2021 - 11/2010
2	Endovascular Procedures 01/2021 - 02/2019
2	Combined Modality Therapy 01/2021 - 11/2017
2	Induction Chemotherapy 01/2020 - 11/2017
2	Contraindications 05/2012 - 02/2004
1	Immunotherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Nasal Surgical Procedures 05/2021
1	Ventriculostomy 02/2021
1	Reoperation 01/2021
1	Biological Therapy 12/2020
1	Ambulatory Care (Outpatient Care) 11/2020
1	Treatment Delay 07/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2020
1	Salvage Therapy 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Tracheostomy 01/2020
1	Surgical Instruments (Clip) 03/2019
1	Ligation 06/2018
1	Free Tissue Flaps 01/2017
1	Operative Time 02/2016